Xibus
Boston, US · 4 employees on LinkedIn · 2 known investors
Xibus Systems develops a pathogen detection system that combines engineered bio-molecules, super fluorescent nano-beads, custom bacterial growth media, and AI analytical software to detect disease-causing bacteria in foods and beverages. The company serves the food and beverage safety industry with faster, more sensitive bacterial detection.
Also known as Xibus Systems
Investors · 2
Company profile
researched Aug 2026Xibus Systems is a venture-backed company based in the Boston metropolitan area that develops a pathogen detection system for the food and beverage industry. The system is built on four core technologies: engineered bio-molecules licensed from MIT, super fluorescent nano-beads developed in-house, custom bacterial growth media, and AI analytical software.
The company positions these combined technologies as a way to identify disease-causing bacteria in foods and beverages with greater speed and sensitivity than conventional testing, addressing the need to test products before they are shipped or spoil. The company's website states that Xibus Systems has merged with Fluorityx Inc.
Latest developments
The company's website announces that Xibus Systems has merged with Fluorityx Inc., pointing visitors to fluorityx.com.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
The company operates in food and beverage safety testing, where it frames its approach as combining bioengineering, nanotechnology and AI in a single pathogen detection system.
Technology
The detection platform integrates MIT-licensed engineered bio-molecules, company-developed super fluorescent nano-beads, custom bacterial growth media, and AI analytical software. Together these components are used to detect pathogenic bacteria in food and beverage samples, with the stated aim of improving both the speed and the sensitivity of bacterial testing.
Go-to-market
Food and beverage producers and testers that must screen products for disease-causing bacteria before shipment or spoilage.
Geography
Headquartered in the Boston metropolitan area, United States.
History
Xibus Systems was established as a venture-backed startup in the Boston metropolitan area, building its product around biomolecules licensed from MIT alongside internally developed fluorescent beads, growth media and analytical software. It has since merged with Fluorityx Inc.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Timeline · 1
launches, deals, and filingsA notice on the Xibus Systems website states that the company has merged with Fluorityx Inc. and directs visitors to fluorityx.com.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 1
primary sources listed
- Xibusxibus.systems · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Xibus do?
- Xibus Systems builds a bioengineering, nanotechnology and AI-based system for detecting pathogenic bacteria in food and beverages.
- Who are Xibus's investors?
- Xibus's investors include Newlin Investment Company LLC, Safar Partners.
- Where is Xibus headquartered?
- Xibus is headquartered in Boston, US.